We are live on
!
Find out more
TRCT
Tower Research Capital (TRC) Portfolio holdings
AUM
$4.08B
1-Year Est. Return
58.77%
This Fund
S&P 500
This Quarter
Est. Return
+9.34%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$9.03B
AUM Growth
+$6.6B
(+271%)
Cap. Flow
+$1.53B
Cap. Flow
% of AUM
16.94%
Top 10 Holdings %
Top 10 Hldgs %
64.29%
Holding
5,395
New
546
Increased
3,017
Reduced
1,240
Closed
466
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$487M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$48.2M |
| 3 |
iShares MSCI Emerging Markets ETF
EEM
|
+$29.4M |
| 4 |
iShares MSCI EAFE ETF
EFA
|
+$28.9M |
| 5 |
Microsoft
MSFT
|
+$27.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
|
+$51.8M |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$38.5M |
| 3 |
Direxion Daily Semiconductor Bull 3X ETF
SOXL
|
+$32.6M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$21M |
| 5 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$16.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.25% |
| 2 | Industrials | 4.6% |
| 3 | Consumer Discretionary | 4.31% |
| 4 | Healthcare | 4.26% |
| 5 | Financials | 3.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LACK
2576
DELISTED
Direxion Daily Consumer Staples Bear 3X Shares
LACK
| $201K | ﹤0.01% |
23,458
+15,983
| +214% | +$150K |
|
2577
Plains GP Holdings
PAGP
$4.98B
| $200K | ﹤0.01% |
32,910
+16,589
| +102% | +$127K |
|
2578
Invesco S&P 500 Pure Value ETF
RPV
$1.74B
| $200K | ﹤0.01% |
4,071
+1,373
| +51% | +$68.4K |
|
|
CLDT
2579
Chatham Lodging
CLDT
$590M
| $199K | ﹤0.01% |
26,130
+21,240
| +434% | +$139K |
|
2580
Southern Missouri Bancorp
SMBC
$850M
| $199K | ﹤0.01% |
8,420
+7,112
| +544% | +$163K |
|
2581
Tyler Technologies
TYL
$13B
| $199K | ﹤0.01% |
570
-4,493
| -89% | -$1.55M |
|
|
AGRX
2582
DELISTED
Agile Therapeutics
AGRX
| $199K | ﹤0.01% |
33
+31
| +1,550% | +$178K |
|
|
GFLU
2583
DELISTED
GFL Environmental Inc. Tangible Equity Units
GFLU
| $199K | ﹤0.01% |
3,724
-1,619
| -30% | -$84.2K |
|
|
BPY
2584
DELISTED
Brookfield Property Partners L.P. Limited Partnership Units
BPY
| $199K | ﹤0.01% |
16,538
-57,144
| -78% | -$653K |
|
2585
Crown Holdings
CCK
$13.1B
| $198K | ﹤0.01% |
+2,578
| New | +$189K |
|
2586
Veritone
VERI
$139M
| $198K | ﹤0.01% |
21,668
+20,529
| +1,802% | +$216K |
|
|
BMTC
2587
DELISTED
Bryn Mawr Bank Corp
BMTC
| $198K | ﹤0.01% |
7,945
+5,199
| +189% | +$139K |
|
2588
First Capital
FCAP
$220M
| $197K | ﹤0.01% |
3,511
+2,891
| +466% | +$175K |
|
2589
Paysign
PAYS
$723M
| $197K | ﹤0.01% |
34,684
+27,881
| +410% | +$217K |
|
|
IHC
2590
DELISTED
Independence Holding Company
IHC
| $197K | ﹤0.01% |
5,235
+4,358
| +497% | +$151K |
|
2591
American Financial Group
AFG
$12B
| $196K | ﹤0.01% |
2,918
-4,655
| -61% | -$300K |
|
|
BBT
2592
Beacon Financial Corp
BBT
$2.71B
| $196K | ﹤0.01% |
19,323
+12,287
| +175% | +$121K |
|
2593
Fulton Financial
FULT
$4.67B
| $196K | ﹤0.01% |
21,023
-13,200
| -39% | -$130K |
|
2594
LifeVantage
LFVN
$82.1M
| $196K | ﹤0.01% |
16,237
+13,169
| +429% | +$178K |
|
2595
RCI Hospitality Holdings
RICK
$214M
| $196K | ﹤0.01% |
9,608
+7,698
| +403% | +$122K |
|
2596
Verastem
VSTM
$604M
| $196K | ﹤0.01% |
13,540
+1,303
| +11% | +$21.6K |
|
|
YARW
2597
Yarrow Bioscience, Inc. Common Stock
YARW
$114M
| $196K | ﹤0.01% |
33
+29
| +725% | +$169K |
|
2598
Invesco S&P SmallCap Momentum ETF
XSMO
$3.11B
| $196K | ﹤0.01% |
4,895
-2,338
| -32% | -$91.8K |
|
|
NEX
2599
DELISTED
NexTier Oilfield Solutions Inc.
NEX
| $196K | ﹤0.01% |
105,783
+71,523
| +209% | +$173K |
|
|
CXP
2600
DELISTED
COLUMBIA PROPERTY TRUST, INC.
CXP
| $196K | ﹤0.01% |
18,007
+7,669
| +74% | +$91.5K |
|
Similar funds
CA
ICP
AP
BWA
JSW
SP
GCM
ZP
Tower Research Capital (TRC)'s Q3 2020 Portfolio in Review
As of Q3 2020, Tower Research Capital (TRC) held 5,395 positions worth $9.03B, up 271% from $2.44B the previous quarter. Its ten largest holdings account for 64% of the portfolio.
Tower Research Capital (TRC) deployed $1.53B of net new capital in Q3 2020, opening 546 new positions and adding to 3,017 existing holdings. Its largest new stake was iShares Biotechnology ETF: 34,723 shares worth $4.7M.
By sector, the portfolio is most concentrated in Technology at 6.3% of assets, down from 12% a quarter earlier, followed by Industrials and Consumer Discretionary.
On the sell side, the largest reduction was Vanguard S&P 500 ETF, an estimated $38.5M trimmed.
- Tower Research Capital (TRC)'s largest Q3 2020 buy was iShares Biotechnology ETF: 34,723 shares worth $4.7M.
- Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2020, an estimated $487M increase.
- Tower Research Capital (TRC)'s biggest Q3 2020 reduction was Vanguard S&P 500 ETF, cutting an estimated $38.5M.
- Tower Research Capital (TRC) fully exited iPath Series B S&P 500 VIX Short-Term Futures ETN in Q3 2020, selling an estimated $51.8M.
- Tower Research Capital (TRC)'s ten largest holdings make up 64% of its $9.03B portfolio in Q3 2020.
- Tower Research Capital (TRC) opened 546 new positions and closed 466 in Q3 2020.
- Tower Research Capital (TRC)'s portfolio value rose 271% quarter-over-quarter to $9.03B.
Based on Tower Research Capital (TRC)'s 13F filing for Q3 2020, filed 16 Nov 2020.